摘要:
A modified bio-related substance, wherein at least one poly(alkylene glycol)oxy group represented by the following formula (1) is combined in a molecule: wherein R is a hydrocarbon group having 1 to 24 carbon atoms, OA1 and OA2 are each an oxyalkylene group having 2 to 4 carbon atoms, the groups represented by R are the same or different from each other in one molecule, and the groups represented by OA2 are the same or different from each other in one molecule, n and m are each average number of moles of the oxyalkylene group added, n represents 0 to 1000, and m represents 10 to 1000.
摘要:
An aspect of the invention provides a sliding component in which a phase made of liquid and a phase made of gas, which are formed in a sliding portion, are stabilized. A sliding component constitutes one of two sliding components that rotate relatively, and planar end faces of the two sliding component slide on each other. In the sliding component, a plurality of dimples is arrayed in a sliding surface such that, in a phase made of liquid and a phase made of gas, the phase made of the gas is positioned when the two components rotate relatively. The phase made of the liquid and the phase made of the gas are formed so as to revolve about rotation centers of sliding portions of the two components.
摘要:
In a digital broadcasting signal receiving/recording/reproducing apparatus, a recorded program can be immediately reproduced without performing complicated operations. Only a desired program and information related to the desired program are separated to be extracted from the digital broadcasting signal. Then, the separated/extracted broadcasting signal is supplied to a recording/reproducing apparatus. In the recording/reproducing apparatus, the supplied broadcasting signal is recorded, and the recorded program can be immediately reproduced without complicated manipulating operations during the signal reproducing operation.
摘要:
Provided is an orthogonality compensating device that compensates for orthogonality between a real signal and an imaginary signal of complex digital intermediate frequency signals, the orthogonality compensating device including: a first processing unit that outputs a first signal obtained by calculating one of the real signal and the imaginary signal by using a first coefficient and a second coefficient; and a coefficient specifying unit that specifies the first coefficient such that the first signal has the same amplitude as the other of the real signal and the imaginary signal, and specifies the second coefficient such that the first signal is orthogonal to the other of the real signal and the imaginary signal, by using the first signal and the other of the real signal and the imaginary signal.
摘要:
The problems of the present invention are to find a pharmaceutical composition and a method for treating cancer that exhibit excellent anti-tumor effect. Excellent anti-tumor effect is achieved when 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or an analogous compound thereof, a pharmacologically acceptable salt thereof or a solvate thereof is used in combination with an anti-tumor platinum complex.
摘要:
Provided is a recording or playback apparatus capable of separating a musical piece from an audio including the musical piece and a speech through a simple arithmetic process. A cut point detector detects, as a cut point, a time point at which an audio signal level or an amount of change in the audio signal level is not lower than a predetermined value. A frequency characteristic amount calculator calculates a characteristic amount in a frequency area of the audio signal only at each cut point and in its proximity. A cut point judging unit judges an attribute of the cut point on a basis of the calculated characteristic amount of the frequency. A music section detector detects a start and end points of each music section on a basis of the attribute and an interval between sampling points.
摘要:
Disclosed are: a therapeutic agent, a kit and a treatment method for undifferentiated gastric cancer; and a pharmaceutical composition, a kit and a treatment method which are more effective on a living organism having at least one cell selected from the group consisting of a cell overexpressing FGFR2 and a cell expressing a mutant FGFR2. A combination of a FGFR2 inhibitor and a therapeutic substance for gastric cancer is more effective on undifferentiated gastric cancer. The combination of a FGFR2 inhibitor and a therapeutic substance for gastric cancer is more effective on a living organism having at least one cell selected from the group consisting of a cell overexpressing FGFR2 and a cell expressing a mutant FGFR2.